As the geriatric population continues to grow, so does the challenge of polypharmacy. This article outlines strategies to effectively manage polypharmacy and optimize patient outcomes.
Polypharmacy, the concurrent use of multiple medications, is common among the elderly due to the prevalence of chronic diseases. While necessary, it can lead to adverse drug events, drug interactions, and decreased adherence to medication regimens.
A comprehensive medication review is the cornerstone of polypharmacy management. Regularly reviewing the patient's medication list, including over-the-counter drugs and supplements, can identify unnecessary medications, therapeutic duplications, and potential drug interactions.
Deprescribing, the systematic process of identifying and discontinuing drugs in instances where existing or potential harms outweigh current or future benefits, is a key strategy in managing polypharmacy. It requires careful consideration of the patient's overall health status, life expectancy, and preferences.
Pharmacists, as medication experts, have a critical role in managing polypharmacy. They can provide medication therapy management, counsel patients about their medications, and collaborate with other healthcare professionals to optimize medication use.
Technology can assist in managing polypharmacy. Clinical decision support systems can alert healthcare professionals to potential drug-drug interactions, inappropriate dosing, and other medication-related issues.
In conclusion, effective management of polypharmacy in the geriatric population requires a multifaceted approach that includes a comprehensive medication review, deprescribing, pharmacist-led interventions, and the use of technology. By implementing these strategies, healthcare professionals can improve medication safety and patient outcomes in this vulnerable population.
1.
Does Maintenance Therapy Extend Life in mCRC?
2.
What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains
3.
Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement
4.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
5.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
1.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
2.
Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers
3.
Personalized Survivorship Navigation in Precision Cancer Care
4.
Hematopoietic Stem Cell Exhaustion in Blood Disorders
5.
Hematopoietic Clonal Competition in Blood Disorders
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Advances in Modern Cancer Treatment
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
Early Warning Signs of Cancer
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation